Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P39060 (
endostatin
)
2,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We demonstrate here that epithelial carcinoembryonic antigen (CEA)-related cell adhesion molecule-1 (
CEACAM1
) downregulation in prostate intraepithelial neoplasia (PIN) is inversely correlated with its upregulation in adjacent blood vessels.
CEACAM1
silencing in prostate cancer cell line DU-145 via small interfering ribonucleic acid (siRNA) increased but its overexpression suppressed the expression of angiogenic/lymphangiogenic factors such as vascular endothelial growth factor (VEGF)-A, -C and -D, and angiogenic inhibitor collagen 18/
endostatin
. Furthermore,
CEACAM1
overexpression in DU-145 cells increased but
CEACAM1
silencing reduced angiopoietin-1 expression. Inverse relation was found for angiopoietin-2. Supernatant of
CEACAM1
-overexpressing DU-145 suppressed but that of
CEACAM1
-silenced increased the VEGF-induced endothelial tubes. Electron microscopically the majority of PIN-associated blood vessels was structurally destabilized exhibiting endothelial fenestration, trans- and inter-endothelial gaps. In some PIN areas, invasion of single tumor cells into the destabilized blood vessels was observed. These data show that disappearance of epithelial
CEACAM1
in PIN is accompanied by its upregulation in adjacent vasculature which apparently correlates with vascular destabilization and increased vascularization of prostate cancer. Strategies to either conserve the epithelial
CEACAM1
or to target endothelial
CEACAM1
might be useful for an anti-angiogenic therapy of prostate cancer.
...
PMID:CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer. 1656 82